Medication info

Fatimasol Injection

Prescription medicationIntravenous injection
Ingredient · strength
Sodium Chloride›90mg / 100mLPotassium Chloride›149mg / 100mLSodium Lactate Solution›448mg / 100mLGlucose›4.3g / 100mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
A colorless and transparent liquid with a slight salty and sweet taste filled in a colorless and transparent glass or plastic infusion container.
Packaging
200mL/bag, 500mL/bag
Approval status
Active

MFDS item code 200000500 · Notified 2000.11.24 · Insurance code 645102402

Summary

Main use
Improvement through replenishment of fluids and electrolytes (dehydration, before and after surgery) and energy supplementation
Who receives it
Adults · Children
Adult administration
The usual adult dose is 500~1,000mL per dose, administered by intravenous drip. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.
Child administration
For children, administer at a rate of 50~100mL per hour.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement through replenishment of fluids and electrolytes (dehydration, before and after surgery) and energy supplementation

  • Dehydration
  • fluid and electrolyte deficiency
View approved original text

This medication is used to replenish fluids and electrolytes that are deficient due to dehydration or before and after surgery. It also provides the necessary energy to aid in patient recovery. Therefore, it is useful when there is a need to maintain fluid and electrolyte balance and provide energy.

How it is given

Adult administration

The usual adult dose is 500~1,000mL per dose, administered by intravenous drip. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Child administration

For children, administer at a rate of 50~100mL per hour.

Precautions

This medication contains glucose, which may increase the consumption of vitamin B1 (thiamine) in the body when administered intravenously, leading to severe deficiency, so caution is advised. Allergic reactions or hypersensitivity reactions such as anaphylaxis may occur during the administration of this medication. If symptoms occur, administration should be stopped immediately, and appropriate treatment should be initiated. As this solution contains potassium, it should be avoided in patients at risk of hyperkalemia, especially those with impaired renal function or heart disease, or blood potassium levels should be monitored regularly. In diabetic patients or those with difficulty controlling blood sugar, glucose infusion can cause a rapid increase in blood sugar, so blood sugar levels should be monitored frequently, and insulin therapy should be combined if necessary. Due to the sodium and chloride content, electrolyte imbalances such as hypernatremia, hyperchloremia, and metabolic acidosis may occur, so patients with heart or liver disease should be monitored closely. This medication may cause hyponatremia, so especially in children, the elderly, post-surgical patients, and those taking certain medications, blood sodium levels should be monitored periodically. Excessive fluid administration may exacerbate the risk of pulmonary edema or congestive heart failure, so fluid status and electrolyte balance should be monitored carefully. In cases of severe malnutrition when nutritional support is resumed, refeeding syndrome may occur; therefore, potassium, phosphorus, magnesium levels, and thiamine status should be monitored and nutrition should be increased slowly. This medication should be avoided in patients with lactic acidosis, hyperkalemia, hyperhydration, and hyperglycemia, and those with a history of hypersensitivity should not use it. In patients with severely impaired renal function, heart failure, hepatic impairment, or urinary obstruction, greater care should be taken when using this medication, and electrolyte and fluid status should be closely monitored. Rapid or large volume administration of this medication may lead to serious side effects such as cerebral edema, pulmonary edema, and hyperkalemia, so the rate and dosage of administration should be strictly controlled. Regularly monitor blood sugar, electrolyte levels, and fluid balance to detect abnormalities early and respond appropriately. Be cautious of drug interactions, particularly when used with medications that can cause hyperkalemia, lithium, or blood sugar control medications, monitoring their blood concentrations closely. During pregnancy, this medication should only be administered when the therapeutic benefits outweigh the risks to the fetus, and maternal and newborn blood glucose levels should be monitored carefully during delivery. In neonates or low-birth-weight infants, there is a high risk of blood glucose abnormalities and electrolyte imbalances, so careful monitoring is required. Older adults may require dosage adjustment and caution due to decreased bodily function. When administered, a daily dosage of 500mL or more than 20mL per hour is recommended, and care should be taken to prevent air embolism when connecting containers. This medication should be stored in a sealed container to avoid exposure to air and is best kept at room temperature between 1 to 30 degrees Celsius. If stored in a glass container, it can be used safely for 36 months from the manufacturing date, and if stored in an infusion plastic container, it can be used safely for 18 months.

Side effects

  • Cerebral edema
  • pulmonary edema
  • peripheral edema
  • water intoxication
  • hyperkalemia
  • anaphylaxis
  • systemic papules and erythema
  • rash
  • itching
  • vomiting
Show 17 more
  • hypertension
  • tachycardia
  • hyperglycemia
  • hyperosmolar hyperglycemic state
  • hyponatremia
  • fluid overload
  • refeeding syndrome
  • hypernatremia
  • hyperchloremia
  • hyponatremic encephalopathy
  • cardiac arrest
  • chills
  • infusion site blistering
  • extravasation
  • venous thrombosis
  • phlebitis
  • infusion site pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. If contained in a glass container, it can be used for 36 months from the manufacturing date, and if contained in an infusion plastic container, it can be used safely for 18 months.

Appearance and packaging

Appearance

A colorless and transparent liquid with a slight salty and sweet taste filled in a colorless and transparent glass or plastic infusion container.

Package unit

200mL/bag, 500mL/bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.